Information from Industry is developed under the direction and sponsorship of our industry partners, as noted in each episode. Medscape editorial had no part in the creation of these episodes, and each industry partner is solely responsible for the content of the applicable episode. This podcast is intended for healthcare professionals in the United States only.

Are you treating patients with cardiovascular disease? Hear tips for disease management from Dr. Vamsi Krishna, an Assistant Professor at The University of Texas at Austin Dell Medical School and an Interventional Cardiologist and Endovascular Medicine Physician at the Ascension Seton Heart Institute, where he is the Medical Director of both the Cardiac Catheterization Lab and the Cardiac Rehabilitation Center. Dr. Krishna covers key aspects of ASCVD management for your patient – most critically LDL-C lowering, including discussion of a treatment option. Relevant disclosures, transcript, and more can be found on Medscape (https://www.medscape.com/brandplay/338730.1).

Abbreviations:

ACC, American College of Cardiology; ACS, acute coronary syndrome; AHA, American Heart Association; ASCVD, atherosclerotic cardiovascular disease; CHD, coronary heart disease; CV, cardiovascular; IS, ischemic stroke; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; non-HDL-C, non- high-density lipoprotein; PAD, peripheral artery disease; US, United States.

References:

1. National Library of Medicine. https://medlineplus.gov/ency/patientinstructions/000759.htm. Accessed July 1, 2024.

2. Ference BA, et al. Eur Heart J. 2017;38:2459-2472.
3. Spertus J, et al. J Am Coll Cardiol. 2018;71(suppl 11):A24.
4. Muntner P, et al. Cardiovasc Drugs Ther. 2022;36:475-481.
5. Fonarow GC, et al. Clin Cardiol. 2021;44:1327-1481.
6. Grundy SM, et al. J Am Coll Cardiol. 2019;73:e285-e350.
7. Amgen. News release; July 11, 2016.
8. Zhang J, et al. Front Nutr. 2023;9:1044329.
9. Stitziel NO, et al. Trends Mol Med. 2020;26:744-757.
10. Lee M, et al. JAMA Neurol. 2022;79(4):349-358.
11. Sabatine MS, et al. N Engl J Med. 2017;376:1713-1722.
12. Sniderman AD, et al. Circ Cardiovasc Qual Outcomes. 2011;4:337-345. 13. Data on file, Amgen; 2023.
14. Lloyd-Jones DM, et al. J Am Coll Cardiol. 2022;80:1366-1418.
15. Paul B, et al. JHEP Rep. 2022;4:100479.

Are you treating patients with cardiovascular disease? Hear tips for disease management. Dr. Vamsi Krishna presents clinical data for a treatment option. Additional considerations include common barriers to treatment. Relevant disclosures, transcript, and more can be found on Medscape (https://www.medscape.com/brandplay/338730.1).

Abbreviations:

ACC, American College of Cardiology; ASCVD, atherosclerotic cardiovascular disease; ACS, acute coronary syndrome; CHF, congestive heart failure; CKD, chronic kidney disease; CV, cardiovascular; CVD, cardiovascular disease; LDL-C, low-density lipoprotein cholesterol; MI, myocardial infarction; PAD, peripheral artery disease; US, United States; VHR, very high risk.

References:
1. Sabatine MS, et al. N Engl J Med. 2017;376:1713-1722.
2. Lloyd-Jones DM, et al. J Am Coll Cardiol. 2022;80:1366-1418.
3. Ference BA, et al. Eur Heart J. 2017;38:2459-2472.
4. Data on file, Amgen; 2022.
5. O'Donoghue ML, et al. Circulation. 2022;146:1109-1119.
6. Product Prescribing Information.
7. MacDougall DE, et al. Circ Cardiovasc Qual Outcomes. 2024;17:e009988.

8. Data on file, Amgen; 2024.

9. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a615043.html. Accessed July 1, 2024.